CordenPharma Injectables Platform

CordenPharma Injectables Platform
Product Description

Your Expert Partner for Clinical & Commercial Injectable Drug Product Supply

  • >> Wide & balanced range of injectable services incl. capability for combining injectable drugs and devices (combination products)
  • >> Aseptic and Terminal Sterilization Fill & Finish Technologies forPre-Filled Syringes (PFS), ampoules, liquid and lyophilized vials, supporting a wide range of filling volumes
  • >> Substantial Drug Product regulatory and filing experience globally (EMEA, FDA, PMDA)
  • >> Full-service CDMO offering, project management & integrated supply from APIs to final Drug Products>> Packaging / labeling
  • >> Clinical trial drug kit management (logistics, track & trace,documentation)

Corden Pharma International GmbH

  • DE
  • 2015
    On CPHI since
  • 1
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Specifications
  • Selling Points
    Experienced Technicians; International Approvals/Standards; Packaging; Place of Origin; Product Performance; Prompt Delivery; Quality Service; Reputation
  • Supplied from
    Italy
  • Measured In
    piece

Corden Pharma International GmbH

  • DE
  • 2015
    On CPHI since
  • 1
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO

More Products from Corden Pharma International GmbH (4)

  • CordenPharma Lipids & Carbohydrate Platform

    Product CordenPharma Lipids & Carbohydrate Platform

    Your Expert Partner for Standard & Proprietary Lipids & Carbohydrates
    • >> A specialized Lipids offering including custom and standard lipids (Glycero-Phospholipids, Sphingolipids, Phosphocholine, Pegylated, and Cationic Lipids). • >> Lipids for support of mRNA vaccine pro...
  • CordenPharma Peptides Platform

    Product CordenPharma Peptides Platform

    Your Expert Partner for Peptide APIs
    • >> Proven track record delivering world class manufacturing services from early stage to commercial supply, including complex products (e.g., Linaclotide, Enfuvirtide, Mifamurtide, Eptifibatide, Glatiramer, GLP analogues). • >> Proprietary pr...
  • CordenPharma Highly Potent & Oncology Platform

    Product CordenPharma Highly Potent & Oncology Platform

    One Source for Highly Potent & Oncological Products
    • Integrated Supply: APIs & Oral / Sterile Drug Products • State-of-the-art facilities able to handle API and Drug Product of the highest potency • Development, clinical trial and commercial manufacturing • Full-service offering including ...
  • CordenPharma Small Molecules Platform

    Product CordenPharma Small Molecules Platform

    Full-Service Partner of Choice from Advanced Intermediates to Drug Products • Integrated network of cGMP facilities across Europe and US • 1,200 m3 of volumetric capacity in 20 L - 28,000 L reactors with various materials of construction • Clinical (Phase I-III) and ongoing commercial supply to multiple mar...

Corden Pharma International GmbH resources (4)

  • News Press Release > CordenPharma Colorado Expands Lipid Excipients Purification

    Luxembourg, 19 April 2021 -- In response to the COVID-19 pandemic, mRNA (messenger RNA) vaccines have catapulted to center stage of the pharmaceutical and biotechnology industry. As of early 2021, there are eight ongoing human trials for mRNA vaccines led by Moderna, BioNTech / Pfizer, CureVac, Sanofi / TranslateBio, Arcturus / Duke-NUS Medical School (Singapore), Imperial College London, Chulalongkorn University (Thailand), and Providence Therapeutics.
  • Brochure Brochure > Drug Product Services

    Highlights CordenPharma's capabilities for Oral Solid Dosage and Non-Sterile Dosage forms as well as Sterile Injectable Drug Product manufacturing.
  • Video Video > CordenPharma Injectable Drug Product Manufacturing

    Let us accompany you on your Sterile Injectable Drug Product journey under CordenPharma's Injectable Technology Platform. Our CordenPharma Caponango (IT) manufacturing facility produces liquid dosage forms with expertise in GMP Manufacturing, Aspetic Fill & Finish, Terminal Sterilization, Clinical Trials, and Pharma-Logistics.
  • Webinar LIVE WEBINAR > Your Injectable Roadmap: Tues Oct 13, 16:00 CEST / 10 EDT

    Speakers: Mark Chipperfield (Corvus Ltd), Fabio Stevanon (CordenPharma), Umberto Romeo (CordenPharma)
    Key Learning Objectives:
    Review the fundamentals of combined injectable delivery device - drug products. Get an update on the latest regulation landscape for combined drug-device products, including some technical challenges for injectable Pre-Filled Syringes (PFS) & Auto-injectors. Gain insight into sound Injectable Drug Product strategy from a Full-Service CDMO industry leader. Learn about recent injectable industry changes facing Pharma, especially in the “New Normal” COVID-19 era, and how CordenPharma’s successful response & expanded capabilities can best support your drug development goals. Learn from an R&D Expert on ways to efficiently develop & commercialize an injectable drug.